Related Experiment Video
Updated: Aug 6, 2025

Author Spotlight: Expression and Purification of Human Solute Carrier Transporters Using Codon-Optimized Genes
Published on: September 29, 2023
Cation/proton antiporters: novel structure-driven pharmaceutical opportunities
Gal Masrati1, Amit Kessel1, Nir Ben-Tal1
1Tel Aviv University, George S. Wise Faculty of Life Sciences, Department of Biochemistry and Molecular Biology, Tel Aviv, Israel.
Cation/proton antiporters (CPAs) are vital for cellular salt and pH balance. New protein structures and computational methods offer promising avenues for developing novel CPA-targeting therapeutics to treat associated human diseases.
Area of Science:
- Biochemistry
- Molecular Biology
- Pharmacology
Background:
- Cation/proton antiporters (CPAs) play a critical role in maintaining cellular homeostasis, regulating ion concentrations and pH balance.
- Dysfunctional CPAs are implicated in various human diseases, highlighting their importance in health and disease.
- Despite their significance, the development of therapeutics targeting CPAs has been limited.
Purpose of the Study:
- To review recent advancements in understanding CPA structure and function.
- To explore the potential of emerging computational technologies in CPA drug discovery.
- To bridge the gap between fundamental research and clinical development of CPA-targeting drugs.
Main Methods:
- Analysis of recently published mammalian CPA protein structures.
- Review of emerging computational techniques, including molecular modeling and simulation.
- Integration of structural and computational data for drug target identification.
Main Results:
- Detailed structural insights into mammalian CPAs have been elucidated.
- Computational technologies show significant potential for predicting drug interactions and guiding therapeutic design.
- A synergistic approach combining structural biology and computational methods can accelerate CPA drug discovery.
Conclusions:
- Recent structural data provides a foundation for rational drug design targeting CPAs.
- Emerging computational tools offer powerful strategies to overcome current limitations in CPA therapeutic development.
- This integrated approach holds promise for advancing novel therapeutics for CPA-related pathologies.
More Related Videos
Related Concept Videos
Pore Transport and Ion-Pair Transport
Pore transport, also known as convective transport, is a process where small molecules like urea, water, and sugars rapidly cross cell membranes as though there were channels or pores in the membrane. Although direct microscopic evidence is limited but the concept of pores or channels is widely accepted based on physiological evidence. Despite the lack of direct...
Drug Absorption Mechanism: Carrier-Mediated Membrane Transport
Facilitated diffusion is a passive process that utilizes human Solute Carrier (SLC) transporters. These transporters bind to the drug, undergo structural...
Active Transport
Primary active transporters, like Na+, K+ and -ATPase, directly utilize ATP to move ions across the membrane. These transporters play significant roles in various physiological processes. For instance, Na+, K+ and -ATPase maintain...
Carrier-Mediated Transport
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Facilitated Diffusion
In this process, substrates such as organic compounds and ions interact with a transporter on one side, triggering conformational changes in proteins that enable...
Secondary Active Transport

